Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, random... by Chi, Kim N, Prof, Higano, Celestia S, MD, Blumenstein, Brent, PhD, Ferrero, Jean-Marc, Prof, Reeves, James, MD, Feyerabend, Susan, MD, Gravis, Gwenaelle, MD, Merseburger, Axel S, Prof, Stenzl, Arnulf, Prof, Bergman, Andries M, MD, Mukherjee, Som D, MD, Zalewski, Pawel, MD, Saad, Fred, Prof, Jacobs, Cindy, MD, Gleave, Martin, Prof, de Bono, Johann S, Prof

Get full text